&nbsp;

Thyroid ASIR-F 1999-2003.jpg

May 2018

Document

Thyroid ASIR-F 2009-2013.jpg

May 2018

Document

CCO Participant Info Form-FR

May 2018

Regimen

CHOP

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

ODB - General Benefit

prednisone

Drugs Used:

Quick Link(s):

Regimen Monograph

May 2018

Regimen

CRBPPEME+BEVA

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Drugs Used:

pemetrexed,

CARBOplatin,

bevacizumab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2021

Regimen

CISPPEME(RT)

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative, Adjuvant

Drugs Used:

pemetrexed,

CISplatin

... Show more tags

Quick Link(s):

Regimen Monograph

Jan 2019

Regimen

CISPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2022

Regimen

CRBPPEME+PEMB

Cancer Type:

Lung,

Non-Small Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Drugs Used:

Quick Link(s):

Regimen Monograph

Aug 2022

Document

TobaccoWiseBrochureFirstNations.pdf

Jun 2018

Document

TobaccoWiseBrochureInuit.pdf

Jun 2018

Guidelines and Advice

The Role of Primary Tumour Location in the Selection of Biologics for the Treatment of Unresectable Metastatic Colorectal Cancer: An Endorsement of a Canadian Consensus Statement

Status: Current
ID: GL END 2-31

Jul 2018

Regimen

CABO

Cancer Type:

Genitourinary,

Renal cell / Kidney

Intent: Palliative

Funding:

Exceptional Access Program

cabozantinib - For the treatment of advanced renal cell carcinoma (RCC), based on criteria

Drugs Used:

cabozantinib (tablet)

... Show more tags